Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Lancet ; 344(8920): 429-31, 1994 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-7520106

RESUMEN

Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic gram-negative bacterial infection. The serum protein lipopolysaccharide-binding protein (LBP) binds to the lipid A component of bacterial endotoxin and facilitates its delivery to the CD14 antigen on the macrophage, where inflammatory cytokines are released and a cascade of host mediators is initiated. The neutrophil granular protein bactericidal/permeability-increasing protein (BPI) competes with LBP for endotoxin binding and functions as a molecular antagonist of LBP-endotoxin interactions. We have measured concentrations of both proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]). The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (rs = 0.81, p < 0.0001). Thus, within abscess cavities BPI is available in sufficient quantities for effective competition with LBP for endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of endotoxin release during gram-negative infections.


Asunto(s)
Absceso/patología , Proteínas de Fase Aguda , Infecciones Bacterianas/patología , Actividad Bactericida de la Sangre , Proteínas Sanguíneas/análisis , Líquidos Corporales/química , Proteínas Portadoras/análisis , Glicoproteínas de Membrana , Proteínas de la Membrana , Neutrófilos , Peritonitis/patología , Absceso/inmunología , Absceso/microbiología , Anciano , Péptidos Catiónicos Antimicrobianos , Infecciones Bacterianas/inmunología , Infecciones Bacterianas/microbiología , Unión Competitiva , Proteínas Sanguíneas/química , Proteínas Sanguíneas/inmunología , Proteínas Portadoras/química , Proteínas Portadoras/inmunología , Femenino , Humanos , Inflamación , Masculino , Persona de Mediana Edad , Peritonitis/inmunología , Peritonitis/microbiología , Permeabilidad
2.
Clin Nephrol ; 40(6): 346-51, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7507806

RESUMEN

Several proteins modify the biological response to lipopolysaccharide (LPS). Both bactericidal/permeability-increasing factor (BPI), a protein stored in neutrophils, and the acute phase protein LPS-binding protein (LBP) bind to LPS; however, BPI inhibits while LBP enhances binding of LPS to leukocytes and subsequent induction of cytokines. We investigated plasma levels of BPI, LBP, elastase and C5a before, during and after hemodialysis (HD). Six patients were dialysed with Cuprophane (Cup) and polysulfone (PS) low-flux dialyzers on two consecutive HD sessions. There was a significant, 10.9 +/- 2.8-fold increase in BPI after 4-hour HD compared to predialysis and a 4.4 +/- 1.6-fold increase in elastase after 4-hour HD using Cup. Plasma levels of BPI and elastase decreased rapidly after the dialysis session. HD with PS resulted in a smaller, but still significant rise in BPI (3.7 +/- 1.6-fold at 4 hours) and elastase (1.69 +/- 0.2-fold at 4 hours). Levels for BPI and elastase were similar in the arterial and venous blood lines of the dialyzer. Plasma levels of LBP did not change during or after the HD session. These data indicate that BPI, but not LBP is released during HD with Cup and to a lesser extent with PS. Activation of neutrophils and release of BPI during HD may influence the biological response to bacterial products possibly introduced during HD.


Asunto(s)
Proteínas de Fase Aguda/análisis , Actividad Bactericida de la Sangre , Proteínas Sanguíneas/análisis , Proteínas Portadoras/sangre , Fallo Renal Crónico/terapia , Glicoproteínas de Membrana , Proteínas de la Membrana , Diálisis Renal , Péptidos Catiónicos Antimicrobianos , Celulosa/análogos & derivados , Complemento C5a/análisis , Ensayo de Inmunoadsorción Enzimática , Humanos , Inmunoensayo , Fallo Renal Crónico/sangre , Membranas Artificiales , Elastasa Pancreática/sangre , Polímeros , Sulfonas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA